[TimAlerts] SCYX also with positive phase 2 data after hours - SCYNEXIS, Inc. Announces Positive Results in its Proof-of-Concept Phase 2 Study of SCY-078, the First Member of a Novel Class of Glucan Synthase Inhibitors


[TimAlerts] Man, both NEOS and SCYX got FDA approvals today and both did great in the premarket and then absolutely collapsed almost immediately after opening


[TimAlerts] SCYX SCYNEXIS, Inc. Receives FDA Fast Track and QIDP Designations for Intravenous Formulation of SCY-078 for the Treatment of Patients with Invasive Fungal InfectionsGlobeNewswire(Thu 9:05AM EST)

of 33